Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Coronary Intervention in Native Coronary Arteries Versus Bypass Grafts in Patients With Prior Coronary Artery Bypass Graft Surgery

Emmanouil S. Brilakis, Colin I. O’Donnell, William Penny, Ehrin J. Armstrong, Thomas Tsai, Thomas M. Maddox, Mary E. Plomondon, Subhash Banerjee, Sunil V. Rao, Santiago Garcia, Brahmajee Nallamothu, Kendrick A. Shunk, Kreton Mavromatis, Gary K. Grunwald and Deepak L. Bhatt

Objectives: The aim of this study was to examine the frequency, associations, and outcomes of native coronary artery versus bypass graft percutaneous coronary intervention (PCI) in patients with prior coronary artery bypass grafting (CABG) in the Veterans Affairs (VA) integrated health care system.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Impact of Access Site on Bleeding and Ischemic Events in Patients With Non–ST-Segment Elevation Myocardial Infarction Treated With Prasugrel

Italo Porto, Leonardo Bolognese, Dariusz Dudek, Patrick Goldstein, Christian Hamm, Jean-François Tanguay, Jurrien ten Berg, Petr Widimský, Nicolas Le Gall, Anthony J. Zagar, LeRoy A. LeNarz, Debra Miller, Gilles Montalescot and ACCOAST Investigators

Objectives: This study assessed whether the choice of vascular access site influenced outcomes among non–ST-segment elevation myocardial infarction (NSTEMI) patients enrolled in the ACCOAST (A Comparison of prasugrel at the time of percutaneous Coronary intervention Or as pre-treatment At the time of diagnosis in patients with non–ST-segment elevation myocardial infarction NCT01015287).

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Clinical Outcomes Following Transcatheter Aortic Valve Replacement in Asian Population

Sung-Han Yoon, Jung-Min Ahn, Kentaro Hayashida, Yusuke Watanabe, Shinichi Shirai, Hsien-Li Kao, Wei-Hsian Yin, Michael Kang-yin Lee, Edgar Tay, Motoharu Araki, Futoshi Yamanaka, Takahide Arai, Mao-Shin Lin, Jun-Bean Park, Duk-Woo Park, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Toshiya Muramatsu, Michiya Hanyu, Ken Kozuma, Hyo-Soo Kim, Shigeru Saito, Seung-Jung Park and Asian TAVR Investigators

Objectives: This study describes the characteristics of a real-world Asian patient population treated with transcatheter aortic valve replacement (TAVR) and evaluates their clinical outcomes.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Giuseppe Tarantini, Marco Mojoli, Stephan Windecker, Olaf Wendler, Thierry Lefèvre, Francesco Saia, Thomas Walther, Paolo Rubino, Antonio L. Bartorelli, Massimo Napodano, Augusto D’Onofrio, Gino Gerosa, Sabino Iliceto and Alec Vahanian

Objectives: The aims of this study were to assess the epidemiology of atrial fibrillation (AF) in patients treated with transcatheter aortic valve replacement (TAVR) and included in the large prospective SOURCE XT (SAPIEN XT Aortic Bioprosthesis Multi-Region Outcome Registry) study and to evaluate their outcomes according to the presence of pre-existing or new-onset AF (NOAF) (defined as AF occurring within 30 days after TAVR).

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Magnetic Resonance Imaging–Guided Transcatheter Cavopulmonary Shunt

Kanishka Ratnayaka, Toby Rogers, William H. Schenke, Jonathan R. Mazal, Marcus Y. Chen, Merdim Sonmez, Michael S. Hansen, Ozgur Kocaturk, Anthony Z. Faranesh and Robert J. Lederman

Objectives: The aim of this study was to test the hypothesis that real-time magnetic resonance imaging (MRI) would enable closed-chest percutaneous cavopulmonary anastomosis and shunt by facilitating needle guidance along a curvilinear trajectory, around critical structures, and between a superior vena cava “donor” vessel and a pulmonary artery “target.”

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Bioresorbable Scaffolds for the Management of Coronary Bifurcation Lesions

Hiroyoshi Kawamoto, Neil Ruparelia, Akihito Tanaka, Alaide Chieffo, Azeem Latib and Antonio Colombo

The use of bioresorbable scaffolds (BRS) may be associated with benefits including restoration of endothelial function, positive vessel remodeling, and reduced risk for very late (stent) thrombosis compared with metallic stents by virtue of their complete absorption within 3 to 4 years of implantation. When treating bifurcation lesions, these advantages may be even more pronounced. The aim of this review is to summarize current experiences and technical considerations of bifurcation treatment with BRS. Because of the physical properties of current-generation BRS, there are concerns with regard to the efficacy and safety of this novel technology for the treatment of bifurcations, with the potential for increased rates of scaffold thrombosis and side-branch occlusions, and as a consequence, bifurcations have been excluded from the major BRS trials. Nevertheless, BRS have been used for this indication in clinical practice, as evidenced by “real-world” registries. Considering the potential limitations, specific technical considerations and modified bifurcation strategies should be used in an attempt to attenuate problems and achieve optimal procedural and clinical outcomes.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Angiographic and Clinical Outcomes After Everolimus-Eluting Stenting for Unprotected Left Main Disease and High Anatomic Coronary Complexity

Angela Migliorini, Renato Valenti, Guido Parodi, Ruben Vergara, Piergiovanni Buonamici, Giampaolo Cerisano, Nazario Carrabba and David Antoniucci

Objectives This study determined angiographic and clinical outcomes after everolimus-eluting stent (EES)–supported percutaneous coronary intervention for unprotected left main disease (ULMD) and high SYNTAX (SYNergy between PCI with TAXus and Cardiac Surgery) trial score (>=33).

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Emergency Percutaneous Coronary Intervention in Post–Cardiac Arrest Patients Without ST-Segment Elevation Pattern

Florence Dumas, Wulfran Bougouin, Guillaume Geri, Lionel Lamhaut, Julien Rosencher, Frédéric Pène, Jean-Daniel Chiche, Olivier Varenne, Pierre Carli, Xavier Jouven, Jean-Paul Mira, Christian Spaulding and Alain Cariou

Objectives: In a large cohort of out-of-hospital cardiac arrest (OHCA) patients without ST-segment elevation (STE), the study assessed the relationship between the use of an early invasive strategy and patient outcome.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes

Shiv K. Agarwal, Srikanth Kasula, Yalcin Hacioglu, Zubair Ahmed, Barry F. Uretsky and Abdul Hakeem

Objectives: This study sought to evaluate the impact of fractional flow reserve (FFR) after percutaneous coronary intervention (PCI) on subsequent in-lab interventional management vessels that had undergone pre-PCI FFR and its prognostic value in predicting long-term (>1 year) outcomes.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Optimal P2Y12 Inhibitor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Asim M. Rafique, Piyush Nayyar, Tracy Y. Wang, Roxana Mehran, Usman Baber, Peter B. Berger, Jonathan Tobis, Jesse Currier, Ravi H. Dave and Timothy D. Henry

Objectives: The study sought to compare the clinical efficacy and safety of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous intervention (PPCI).

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device

Carola Gianni, Luigi Di Biase, Chintan Trivedi, Sanghamitra Mohanty, Yalçin Gökoglan, Mahmut F. Günes, Rong Bai, Amin Al-Ahmad, J. David Burkhardt, Rodney P. Horton, Andrew K. Krumerman, Eugen C. Palma, Miguel Valderrábano, Douglas Gibson, Matthew J. Price and Andrea Natale

Objectives: The aim of this study was to evaluate the incidence and clinical implications of leaks (acute incomplete occlusion, early and late reopenings) following LAA ligation with the LARIAT device.

01 mayo 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Hemodynamic Assessment of Aortic Regurgitation After Transcatheter Aortic Valve Replacement

Robert Höllriegel, Felix Woitek, Razvan Stativa, Norman Mangner, Stephan Haußig, Georg Fuernau, David Holzhey, Friedrich W. Mohr, Gerhard C. Schuler and Axel Linke

Objectives: Assessment of aortic regurgitation (AR) immediately after transcatheter aortic valve replacement (TAVR) is essential to guide further intervention in cases of relevant AR. It was the aim of this study to identify a simple and reproducible hemodynamic parameter for the assessment of AR.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Development and Validation of a Novel Scoring System for Predicting Technical Success of Chronic Total Occlusion Percutaneous Coronary Interventions

Georgios Christopoulos, David E. Kandzari, Robert W. Yeh, Farouc A. Jaffer, Dimitri Karmpaliotis, Michael R. Wyman, Khaldoon Alaswad, William Lombardi, J. Aaron Grantham, Jeffrey Moses, Georgios Christakopoulos, Muhammad Nauman J. Tarar, Bavana V. Rangan, Nicholas Lembo, Santiago Garcia, Daisha Cipher, Craig A. Thompson, Subhash Banerjee and Emmanouil S. Brilakis

Objectives: This study sought to develop a novel parsimonious score for predicting technical success of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) performed using the hybrid approach.

01 enero 2016

JACC: CARDIOVASCULAR INTERVENTIONS. Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold

Michael J. Lipinski, Ricardo O. Escarcega, Nevin C. Baker, Hadiya A. Benn, Michael A. Gaglia Jr., Rebecca Torguson and Ron Waksman

Objectives: The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) by conducting a systematic review and meta-analysis.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.